Pfizer’s Centers for Therapeutic Innovation Hold Apr. 14 Seminar for Intramural Researchers
The National Center for Advancing Translational Sciences will host a seminar on Apr. 14, 2 to 4 p.m., for NIH intramural researchers interested in collaboration opportunities supported through Pfizer’s Centers for Therapeutic Innovation program. The event will take place in Bldg. 40, Rm. 1201/1203 and includes a presentation by Pfizer CTI NIH representative Dr. Nader Halim. To register, send an email to Lili Portilla, NCATS director of strategic alliances, at NIH-PfizerCTI@mail.nih.gov.
The program pairs leading researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. Goals include identifying biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer and together moving the compounds into the clinic to test them.
In addition to the Apr. 14 seminar, Halim will offer office hours from 10 a.m. to 4 p.m. on Apr. 26, May 19 and June 2 in Bldg. 31, Rm. 3B13 to answer questions. The Pfizer CTI pre-proposal portal opens on May 2 with the first call for proposals due June 17. For more information about the program, visit https://ncats.nih.gov/cti. For details about the call for proposals, visit https://ncats.nih.gov/cti/proposals.